Anbio Biotechnology (NASDAQ:NNNN) Shares Up 10% – Still a Buy?

Anbio Biotechnology (NASDAQ:NNNN)’s share price rose 10% during trading on Wednesday . The company traded as high as $26.17 and last traded at $25.85. Approximately 7,355 shares were traded during trading, a decline of 89% from the average daily volume of 68,845 shares. The stock had previously closed at $23.50.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, February 9th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Anbio Biotechnology currently has a consensus rating of “Hold”.

Anbio Biotechnology Stock Up 10.3%

Anbio Biotechnology (NASDAQ:NNNN) last released its earnings results on Tuesday, December 30th. The company reported $0.04 earnings per share for the quarter. The business had revenue of $2.29 million for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.